Name
BridgeBio Pharma, Inc.
Company Description
BridgeBio is a commercial-stage biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials.
Website
Product Categories
International Societies, Professional Associations, Therapeutic Medications
Address
3160 Porter Drive
Suite 250
Palo Alto, 94304
Suite 250
Palo Alto, 94304